Singular Genomics Systems Inc (OMIC)
0.40
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 16:00
0.40
0.00 (0.00%)
After-Hours: 20:00
Singular Genomics Systems Cash from Investing (Quarterly): 0.651M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.651M |
| September 30, 2023 | -24.70M |
| June 30, 2023 | -35.09M |
| March 31, 2023 | 72.94M |
| December 31, 2022 | 0.171M |
| September 30, 2022 | -38.12M |
| June 30, 2022 | -10.01M |
| March 31, 2022 | 8.386M |
| Date | Value |
|---|---|
| December 31, 2021 | -23.32M |
| September 30, 2021 | -5.709M |
| June 30, 2021 | -11.37M |
| March 31, 2021 | -90.46M |
| December 31, 2020 | 7.655M |
| September 30, 2020 | 6.547M |
| June 30, 2020 | 7.407M |
| March 31, 2020 | 2.396M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-90.46M
Minimum
Mar 2021
72.94M
Maximum
Mar 2023
-8.288M
Average
-2.769M
Median
Cash from Investing (Quarterly) Benchmarks
| Bruker Corp | -36.80M |
| Azenta Inc | 98.40M |
| Harvard Bioscience Inc | -1.061M |
| Bionano Genomics Inc | -55.37M |
| Akoya Biosciences Inc | -0.594M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.90M |
| Cash from Financing (Quarterly) | 0.072M |
| Free Cash Flow | -74.62M |
| Free Cash Flow Per Share (Quarterly) | -0.2623 |
| Free Cash Flow to Equity (Quarterly) | -18.02M |
| Free Cash Flow Yield | -256.3% |